nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—germ cell cancer	0.579	1	CbGaD
Prazosin—ABCG2—Dactinomycin—germ cell cancer	0.0516	0.19	CbGbCtD
Prazosin—SLC22A2—Vinblastine—germ cell cancer	0.0438	0.161	CbGbCtD
Prazosin—SLC22A2—Cisplatin—germ cell cancer	0.0401	0.148	CbGbCtD
Prazosin—ABCG2—Cisplatin—germ cell cancer	0.0296	0.109	CbGbCtD
Prazosin—ABCG2—Etoposide—germ cell cancer	0.0291	0.107	CbGbCtD
Prazosin—ABCG2—Methotrexate—germ cell cancer	0.0192	0.0708	CbGbCtD
Prazosin—ABCB1—Dactinomycin—germ cell cancer	0.0186	0.0684	CbGbCtD
Prazosin—ABCB1—Vinblastine—germ cell cancer	0.0117	0.0429	CbGbCtD
Prazosin—ABCB1—Cisplatin—germ cell cancer	0.0107	0.0393	CbGbCtD
Prazosin—ABCB1—Etoposide—germ cell cancer	0.0105	0.0386	CbGbCtD
Prazosin—ABCB1—Methotrexate—germ cell cancer	0.00693	0.0255	CbGbCtD
Prazosin—HTR1D—meninx—germ cell cancer	0.00691	0.0906	CbGeAlD
Prazosin—HTR1D—dura mater—germ cell cancer	0.00636	0.0834	CbGeAlD
Prazosin—MT3—telencephalic ventricle—germ cell cancer	0.00537	0.0704	CbGeAlD
Prazosin—MT3—ganglion—germ cell cancer	0.00334	0.0438	CbGeAlD
Prazosin—HTR1D—trigeminal nerve—germ cell cancer	0.00273	0.0358	CbGeAlD
Prazosin—KCNH6—ganglion—germ cell cancer	0.00238	0.0312	CbGeAlD
Prazosin—Incontinence—Ifosfamide—germ cell cancer	0.00198	0.0452	CcSEcCtD
Prazosin—HTR1D—cranial nerve—germ cell cancer	0.00195	0.0255	CbGeAlD
Prazosin—HTR1D—telencephalic ventricle—germ cell cancer	0.00158	0.0208	CbGeAlD
Prazosin—MT3—brainstem—germ cell cancer	0.00145	0.019	CbGeAlD
Prazosin—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00133	0.0459	CbGpPWpGaD
Prazosin—HTR1A—telencephalic ventricle—germ cell cancer	0.00132	0.0173	CbGeAlD
Prazosin—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00132	0.0454	CbGpPWpGaD
Prazosin—MT3—telencephalon—germ cell cancer	0.00129	0.0169	CbGeAlD
Prazosin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00125	0.0432	CbGpPWpGaD
Prazosin—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00123	0.0423	CbGpPWpGaD
Prazosin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00107	0.0368	CbGpPWpGaD
Prazosin—MT3—medulla oblongata—germ cell cancer	0.00101	0.0133	CbGeAlD
Prazosin—SLC22A1—ganglion—germ cell cancer	0.000995	0.013	CbGeAlD
Prazosin—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.000995	0.0343	CbGpPWpGaD
Prazosin—HTR1D—ganglion—germ cell cancer	0.000986	0.0129	CbGeAlD
Prazosin—KCNH6—telencephalon—germ cell cancer	0.000918	0.012	CbGeAlD
Prazosin—Retinal disorder—Methotrexate—germ cell cancer	0.000916	0.0209	CcSEcCtD
Prazosin—MT3—spinal cord—germ cell cancer	0.000903	0.0118	CbGeAlD
Prazosin—HTR1A—ganglion—germ cell cancer	0.000822	0.0108	CbGeAlD
Prazosin—MT3—endocrine gland—germ cell cancer	0.000813	0.0107	CbGeAlD
Prazosin—MT3—head—germ cell cancer	0.000803	0.0105	CbGeAlD
Prazosin—KCNH7—head—germ cell cancer	0.000803	0.0105	CbGeAlD
Prazosin—HTR1D—blood vessel—germ cell cancer	0.000784	0.0103	CbGeAlD
Prazosin—MT3—testis—germ cell cancer	0.000775	0.0102	CbGeAlD
Prazosin—KCNH7—testis—germ cell cancer	0.000775	0.0102	CbGeAlD
Prazosin—KCNH6—uterus—germ cell cancer	0.000762	0.00998	CbGeAlD
Prazosin—CYP1A1—skin epidermis—germ cell cancer	0.000734	0.00963	CbGeAlD
Prazosin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000719	0.0248	CbGpPWpGaD
Prazosin—KCNH7—cerebellum—germ cell cancer	0.000716	0.00939	CbGeAlD
Prazosin—MT3—cerebellum—germ cell cancer	0.000716	0.00939	CbGeAlD
Prazosin—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000716	0.0247	CbGpPWpGaD
Prazosin—Vasculitis—Ifosfamide—germ cell cancer	0.000708	0.0162	CcSEcCtD
Prazosin—SLC22A2—trigeminal ganglion—germ cell cancer	0.000692	0.00907	CbGeAlD
Prazosin—Urinary incontinence—Ifosfamide—germ cell cancer	0.000667	0.0152	CcSEcCtD
Prazosin—Angina pectoris—Vinblastine—germ cell cancer	0.000585	0.0134	CcSEcCtD
Prazosin—MT3—brain—germ cell cancer	0.000582	0.00763	CbGeAlD
Prazosin—KCNH7—brain—germ cell cancer	0.000582	0.00763	CbGeAlD
Prazosin—KCNH6—head—germ cell cancer	0.000572	0.0075	CbGeAlD
Prazosin—MT3—lymph node—germ cell cancer	0.000562	0.00737	CbGeAlD
Prazosin—ADRA1D—telencephalon—germ cell cancer	0.000509	0.00667	CbGeAlD
Prazosin—HTR1D—trigeminal ganglion—germ cell cancer	0.000484	0.00635	CbGeAlD
Prazosin—Nasal congestion—Cisplatin—germ cell cancer	0.000475	0.0108	CcSEcCtD
Prazosin—SLC22A3—trigeminal ganglion—germ cell cancer	0.000467	0.00612	CbGeAlD
Prazosin—SLC22A3—embryo—germ cell cancer	0.000451	0.00591	CbGeAlD
Prazosin—HTR1D—brainstem—germ cell cancer	0.000429	0.00562	CbGeAlD
Prazosin—MT3—Copper homeostasis—TP53—germ cell cancer	0.000428	0.0148	CbGpPWpGaD
Prazosin—Pancreatitis—Ifosfamide—germ cell cancer	0.000425	0.00971	CcSEcCtD
Prazosin—Alopecia—Vinblastine—germ cell cancer	0.000425	0.0097	CcSEcCtD
Prazosin—Angina pectoris—Ifosfamide—germ cell cancer	0.000422	0.00964	CcSEcCtD
Prazosin—HTR1D—eye—germ cell cancer	0.000417	0.00547	CbGeAlD
Prazosin—KCNH6—brain—germ cell cancer	0.000414	0.00543	CbGeAlD
Prazosin—Pollakiuria—Ifosfamide—germ cell cancer	0.000401	0.00915	CcSEcCtD
Prazosin—Orthostatic hypotension—Cisplatin—germ cell cancer	0.000395	0.00902	CcSEcCtD
Prazosin—Ill-defined disorder—Vinblastine—germ cell cancer	0.000388	0.00887	CcSEcCtD
Prazosin—SLC22A1—telencephalon—germ cell cancer	0.000384	0.00503	CbGeAlD
Prazosin—HTR1D—telencephalon—germ cell cancer	0.00038	0.00499	CbGeAlD
Prazosin—Malaise—Vinblastine—germ cell cancer	0.000377	0.00862	CcSEcCtD
Prazosin—Flushing—Bleomycin—germ cell cancer	0.000377	0.00861	CcSEcCtD
Prazosin—Vertigo—Vinblastine—germ cell cancer	0.000376	0.00859	CcSEcCtD
Prazosin—Pancreatitis—Cisplatin—germ cell cancer	0.000367	0.00837	CcSEcCtD
Prazosin—Sweating increased—Cisplatin—germ cell cancer	0.000364	0.00831	CcSEcCtD
Prazosin—KCNH2—trigeminal ganglion—germ cell cancer	0.000359	0.00471	CbGeAlD
Prazosin—Alopecia—Bleomycin—germ cell cancer	0.000359	0.00819	CcSEcCtD
Prazosin—Abdominal discomfort—Cisplatin—germ cell cancer	0.000358	0.00818	CcSEcCtD
Prazosin—HTR1A—brainstem—germ cell cancer	0.000357	0.00468	CbGeAlD
Prazosin—Bradycardia—Ifosfamide—germ cell cancer	0.000353	0.00807	CcSEcCtD
Prazosin—Discomfort—Vinblastine—germ cell cancer	0.000352	0.00804	CcSEcCtD
Prazosin—Flushing—Dactinomycin—germ cell cancer	0.000352	0.00803	CcSEcCtD
Prazosin—KCNH2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000348	0.012	CbGpPWpGaD
Prazosin—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000346	0.0119	CbGpPWpGaD
Prazosin—Hallucination—Ifosfamide—germ cell cancer	0.000345	0.00789	CcSEcCtD
Prazosin—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000341	0.0118	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000335	0.0116	CbGpPWpGaD
Prazosin—Vasculitis—Methotrexate—germ cell cancer	0.000335	0.00765	CcSEcCtD
Prazosin—Alopecia—Dactinomycin—germ cell cancer	0.000335	0.00764	CcSEcCtD
Prazosin—Sweating increased—Etoposide—germ cell cancer	0.000334	0.00762	CcSEcCtD
Prazosin—KCNH2—Hematopoietic Stem Cell Differentiation—KITLG—germ cell cancer	0.000333	0.0115	CbGpPWpGaD
Prazosin—ADRA1A—brainstem—germ cell cancer	0.000329	0.00432	CbGeAlD
Prazosin—Ill-defined disorder—Bleomycin—germ cell cancer	0.000328	0.00749	CcSEcCtD
Prazosin—ADRA1B—head—germ cell cancer	0.000324	0.00425	CbGeAlD
Prazosin—Tinnitus—Ifosfamide—germ cell cancer	0.000324	0.00739	CcSEcCtD
Prazosin—Flushing—Ifosfamide—germ cell cancer	0.000322	0.00736	CcSEcCtD
Prazosin—ADRA1D—endocrine gland—germ cell cancer	0.000321	0.00421	CbGeAlD
Prazosin—ABCG2—trigeminal ganglion—germ cell cancer	0.00032	0.00419	CbGeAlD
Prazosin—Malaise—Bleomycin—germ cell cancer	0.000319	0.00728	CcSEcCtD
Prazosin—HTR1A—telencephalon—germ cell cancer	0.000317	0.00416	CbGeAlD
Prazosin—ADRA1D—head—germ cell cancer	0.000317	0.00415	CbGeAlD
Prazosin—Paraesthesia—Vinblastine—germ cell cancer	0.000307	0.007	CcSEcCtD
Prazosin—Alopecia—Ifosfamide—germ cell cancer	0.000307	0.007	CcSEcCtD
Prazosin—SLC22A3—gonad—germ cell cancer	0.000306	0.00401	CbGeAlD
Prazosin—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000306	0.00699	CcSEcCtD
Prazosin—Bradycardia—Cisplatin—germ cell cancer	0.000305	0.00696	CcSEcCtD
Prazosin—Discomfort—Bleomycin—germ cell cancer	0.000297	0.00679	CcSEcCtD
Prazosin—Malaise—Dactinomycin—germ cell cancer	0.000297	0.00679	CcSEcCtD
Prazosin—ORM1—bone marrow—germ cell cancer	0.000295	0.00387	CbGeAlD
Prazosin—ORM1—spinal cord—germ cell cancer	0.000294	0.00385	CbGeAlD
Prazosin—Gynaecomastia—Methotrexate—germ cell cancer	0.000293	0.00668	CcSEcCtD
Prazosin—ADRA1A—telencephalon—germ cell cancer	0.000292	0.00383	CbGeAlD
Prazosin—Pain—Vinblastine—germ cell cancer	0.000292	0.00667	CcSEcCtD
Prazosin—Constipation—Vinblastine—germ cell cancer	0.000292	0.00667	CcSEcCtD
Prazosin—Oedema—Bleomycin—germ cell cancer	0.000289	0.00659	CcSEcCtD
Prazosin—Vision blurred—Ifosfamide—germ cell cancer	0.000285	0.0065	CcSEcCtD
Prazosin—ADRA2A—trigeminal ganglion—germ cell cancer	0.000283	0.00371	CbGeAlD
Prazosin—KCNH2—telencephalon—germ cell cancer	0.000282	0.0037	CbGeAlD
Prazosin—Feeling abnormal—Vinblastine—germ cell cancer	0.000282	0.00643	CcSEcCtD
Prazosin—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00028	0.0064	CcSEcCtD
Prazosin—Tinnitus—Cisplatin—germ cell cancer	0.000279	0.00637	CcSEcCtD
Prazosin—Flushing—Cisplatin—germ cell cancer	0.000278	0.00634	CcSEcCtD
Prazosin—Discomfort—Dactinomycin—germ cell cancer	0.000277	0.00633	CcSEcCtD
Prazosin—HTR1D—midbrain—germ cell cancer	0.000273	0.00358	CbGeAlD
Prazosin—Malaise—Ifosfamide—germ cell cancer	0.000272	0.00622	CcSEcCtD
Prazosin—Vertigo—Ifosfamide—germ cell cancer	0.000271	0.0062	CcSEcCtD
Prazosin—Oedema—Dactinomycin—germ cell cancer	0.000269	0.00614	CcSEcCtD
Prazosin—Palpitations—Ifosfamide—germ cell cancer	0.000267	0.0061	CcSEcCtD
Prazosin—SLC22A3—adrenal gland—germ cell cancer	0.000267	0.0035	CbGeAlD
Prazosin—Alopecia—Cisplatin—germ cell cancer	0.000264	0.00604	CcSEcCtD
Prazosin—ORM1—endocrine gland—germ cell cancer	0.000264	0.00346	CbGeAlD
Prazosin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000263	0.006	CcSEcCtD
Prazosin—Paraesthesia—Bleomycin—germ cell cancer	0.000259	0.00592	CcSEcCtD
Prazosin—Dyspnoea—Bleomycin—germ cell cancer	0.000257	0.00587	CcSEcCtD
Prazosin—Arthralgia—Ifosfamide—germ cell cancer	0.000257	0.00587	CcSEcCtD
Prazosin—ABCB1—blood vessel—germ cell cancer	0.000255	0.00335	CbGeAlD
Prazosin—Flushing—Etoposide—germ cell cancer	0.000254	0.00581	CcSEcCtD
Prazosin—Discomfort—Ifosfamide—germ cell cancer	0.000254	0.0058	CcSEcCtD
Prazosin—Hypersensitivity—Vinblastine—germ cell cancer	0.000252	0.00575	CcSEcCtD
Prazosin—ABCG2—telencephalon—germ cell cancer	0.000251	0.00329	CbGeAlD
Prazosin—SLC22A3—female gonad—germ cell cancer	0.000249	0.00326	CbGeAlD
Prazosin—Pain—Bleomycin—germ cell cancer	0.000247	0.00563	CcSEcCtD
Prazosin—Oedema—Ifosfamide—germ cell cancer	0.000247	0.00563	CcSEcCtD
Prazosin—Vision blurred—Cisplatin—germ cell cancer	0.000245	0.00561	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000245	0.0056	CcSEcCtD
Prazosin—Asthenia—Vinblastine—germ cell cancer	0.000245	0.0056	CcSEcCtD
Prazosin—Alopecia—Etoposide—germ cell cancer	0.000242	0.00553	CcSEcCtD
Prazosin—SLC22A1—endocrine gland—germ cell cancer	0.000242	0.00317	CbGeAlD
Prazosin—Ill-defined disorder—Cisplatin—germ cell cancer	0.000242	0.00552	CcSEcCtD
Prazosin—SLC22A1—head—germ cell cancer	0.000239	0.00313	CbGeAlD
Prazosin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000238	0.00544	CcSEcCtD
Prazosin—ABCG2—decidua—germ cell cancer	0.000238	0.00312	CbGeAlD
Prazosin—Feeling abnormal—Bleomycin—germ cell cancer	0.000238	0.00543	CcSEcCtD
Prazosin—HTR1D—head—germ cell cancer	0.000237	0.0031	CbGeAlD
Prazosin—Malaise—Cisplatin—germ cell cancer	0.000235	0.00536	CcSEcCtD
Prazosin—ADRA1B—brain—germ cell cancer	0.000235	0.00308	CbGeAlD
Prazosin—KCNH2—uterus—germ cell cancer	0.000234	0.00307	CbGeAlD
Prazosin—Diarrhoea—Vinblastine—germ cell cancer	0.000234	0.00534	CcSEcCtD
Prazosin—Fatigue—Dactinomycin—germ cell cancer	0.000232	0.0053	CcSEcCtD
Prazosin—SLC22A3—endocrine gland—germ cell cancer	0.000231	0.00303	CbGeAlD
Prazosin—HTR1A—adrenal gland—germ cell cancer	0.000231	0.00302	CbGeAlD
Prazosin—Pain—Dactinomycin—germ cell cancer	0.00023	0.00525	CcSEcCtD
Prazosin—KCNH2—pituitary gland—germ cell cancer	0.00023	0.00301	CbGeAlD
Prazosin—ADRA1D—brain—germ cell cancer	0.00023	0.00301	CbGeAlD
Prazosin—Urticaria—Bleomycin—germ cell cancer	0.000229	0.00523	CcSEcCtD
Prazosin—SLC22A3—head—germ cell cancer	0.000228	0.00299	CbGeAlD
Prazosin—Body temperature increased—Bleomycin—germ cell cancer	0.000228	0.00521	CcSEcCtD
Prazosin—HTR1A—midbrain—germ cell cancer	0.000228	0.00298	CbGeAlD
Prazosin—CYP1A1—skin of body—germ cell cancer	0.000227	0.00298	CbGeAlD
Prazosin—Dizziness—Vinblastine—germ cell cancer	0.000226	0.00516	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000225	0.00513	CcSEcCtD
Prazosin—ADRA2A—telencephalon—germ cell cancer	0.000222	0.00291	CbGeAlD
Prazosin—HTR1A—spinal cord—germ cell cancer	0.000222	0.00291	CbGeAlD
Prazosin—KCNH2—medulla oblongata—germ cell cancer	0.000222	0.00291	CbGeAlD
Prazosin—Feeling abnormal—Dactinomycin—germ cell cancer	0.000222	0.00506	CcSEcCtD
Prazosin—Paraesthesia—Ifosfamide—germ cell cancer	0.000221	0.00506	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—germ cell cancer	0.000221	0.00506	CcSEcCtD
Prazosin—SLC22A3—testis—germ cell cancer	0.000221	0.00289	CbGeAlD
Prazosin—Dyspnoea—Ifosfamide—germ cell cancer	0.00022	0.00502	CcSEcCtD
Prazosin—Somnolence—Ifosfamide—germ cell cancer	0.000219	0.00501	CcSEcCtD
Prazosin—Discomfort—Cisplatin—germ cell cancer	0.000219	0.005	CcSEcCtD
Prazosin—HTR1A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000219	0.00754	CbGpPWpGaD
Prazosin—Vomiting—Vinblastine—germ cell cancer	0.000217	0.00496	CcSEcCtD
Prazosin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000217	0.00748	CbGpPWpGaD
Prazosin—Malaise—Etoposide—germ cell cancer	0.000215	0.00491	CcSEcCtD
Prazosin—Vertigo—Etoposide—germ cell cancer	0.000214	0.0049	CcSEcCtD
Prazosin—Headache—Vinblastine—germ cell cancer	0.000214	0.00489	CcSEcCtD
Prazosin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000214	0.00737	CbGpPWpGaD
Prazosin—Body temperature increased—Dactinomycin—germ cell cancer	0.000213	0.00486	CcSEcCtD
Prazosin—Fatigue—Ifosfamide—germ cell cancer	0.000213	0.00485	CcSEcCtD
Prazosin—Oedema—Cisplatin—germ cell cancer	0.000213	0.00485	CcSEcCtD
Prazosin—Hypersensitivity—Bleomycin—germ cell cancer	0.000213	0.00485	CcSEcCtD
Prazosin—ADRA1A—adrenal gland—germ cell cancer	0.000213	0.00279	CbGeAlD
Prazosin—KCNH7—Circadian rythm related genes—AVP—germ cell cancer	0.000211	0.00729	CbGpPWpGaD
Prazosin—Constipation—Ifosfamide—germ cell cancer	0.000211	0.00481	CcSEcCtD
Prazosin—Pain—Ifosfamide—germ cell cancer	0.000211	0.00481	CcSEcCtD
Prazosin—ADRA2A—decidua—germ cell cancer	0.000211	0.00276	CbGeAlD
Prazosin—HTR1A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00021	0.00726	CbGpPWpGaD
Prazosin—Loss of consciousness—Etoposide—germ cell cancer	0.00021	0.00479	CcSEcCtD
Prazosin—ABCG2—uterus—germ cell cancer	0.000208	0.00273	CbGeAlD
Prazosin—Tachycardia—Cisplatin—germ cell cancer	0.000207	0.00474	CcSEcCtD
Prazosin—Asthenia—Bleomycin—germ cell cancer	0.000207	0.00473	CcSEcCtD
Prazosin—Hyperhidrosis—Cisplatin—germ cell cancer	0.000206	0.00469	CcSEcCtD
Prazosin—KCNH2—adrenal gland—germ cell cancer	0.000205	0.00269	CbGeAlD
Prazosin—ABCG2—pituitary gland—germ cell cancer	0.000204	0.00268	CbGeAlD
Prazosin—Pruritus—Bleomycin—germ cell cancer	0.000204	0.00466	CcSEcCtD
Prazosin—Feeling abnormal—Ifosfamide—germ cell cancer	0.000203	0.00464	CcSEcCtD
Prazosin—Nausea—Vinblastine—germ cell cancer	0.000203	0.00463	CcSEcCtD
Prazosin—KCNH2—midbrain—germ cell cancer	0.000203	0.00266	CbGeAlD
Prazosin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000202	0.00698	CbGpPWpGaD
Prazosin—Pancreatitis—Methotrexate—germ cell cancer	0.000201	0.00459	CcSEcCtD
Prazosin—Discomfort—Etoposide—germ cell cancer	0.000201	0.00458	CcSEcCtD
Prazosin—HTR1A—endocrine gland—germ cell cancer	0.0002	0.00262	CbGeAlD
Prazosin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000199	0.00687	CbGpPWpGaD
Prazosin—KCNH2—bone marrow—germ cell cancer	0.000199	0.0026	CbGeAlD
Prazosin—Hypersensitivity—Dactinomycin—germ cell cancer	0.000198	0.00453	CcSEcCtD
Prazosin—KCNH2—spinal cord—germ cell cancer	0.000198	0.00259	CbGeAlD
Prazosin—CYP1A1—uterus—germ cell cancer	0.000198	0.00259	CbGeAlD
Prazosin—HTR1A—head—germ cell cancer	0.000197	0.00259	CbGeAlD
Prazosin—ABCG2—medulla oblongata—germ cell cancer	0.000197	0.00259	CbGeAlD
Prazosin—Abdominal discomfort—Methotrexate—germ cell cancer	0.000197	0.00449	CcSEcCtD
Prazosin—Urticaria—Ifosfamide—germ cell cancer	0.000196	0.00447	CcSEcCtD
Prazosin—Body temperature increased—Ifosfamide—germ cell cancer	0.000195	0.00445	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000194	0.00442	CcSEcCtD
Prazosin—Asthenia—Dactinomycin—germ cell cancer	0.000193	0.00441	CcSEcCtD
Prazosin—KCNH2—female gonad—germ cell cancer	0.000191	0.00251	CbGeAlD
Prazosin—Paraesthesia—Cisplatin—germ cell cancer	0.000191	0.00436	CcSEcCtD
Prazosin—Tachycardia—Etoposide—germ cell cancer	0.00019	0.00434	CcSEcCtD
Prazosin—Dyspnoea—Cisplatin—germ cell cancer	0.00019	0.00433	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—germ cell cancer	0.000189	0.00431	CcSEcCtD
Prazosin—Hyperhidrosis—Etoposide—germ cell cancer	0.000188	0.0043	CcSEcCtD
Prazosin—KCNH2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000186	0.00642	CbGpPWpGaD
Prazosin—ADRA2A—gonad—germ cell cancer	0.000185	0.00243	CbGeAlD
Prazosin—ADRA1A—endocrine gland—germ cell cancer	0.000184	0.00242	CbGeAlD
Prazosin—ADRA2A—uterus—germ cell cancer	0.000184	0.00242	CbGeAlD
Prazosin—Diarrhoea—Dactinomycin—germ cell cancer	0.000184	0.0042	CcSEcCtD
Prazosin—Vomiting—Bleomycin—germ cell cancer	0.000183	0.00419	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—germ cell cancer	0.000183	0.00418	CcSEcCtD
Prazosin—ORM1—lymph node—germ cell cancer	0.000183	0.0024	CbGeAlD
Prazosin—ABCG2—adrenal gland—germ cell cancer	0.000183	0.00239	CbGeAlD
Prazosin—ADRA1A—head—germ cell cancer	0.000182	0.00239	CbGeAlD
Prazosin—Rash—Bleomycin—germ cell cancer	0.000182	0.00415	CcSEcCtD
Prazosin—Pain—Cisplatin—germ cell cancer	0.000182	0.00415	CcSEcCtD
Prazosin—Dermatitis—Bleomycin—germ cell cancer	0.000182	0.00415	CcSEcCtD
Prazosin—Hypersensitivity—Ifosfamide—germ cell cancer	0.000182	0.00415	CcSEcCtD
Prazosin—ADRA2A—pituitary gland—germ cell cancer	0.000181	0.00237	CbGeAlD
Prazosin—ABCG2—midbrain—germ cell cancer	0.00018	0.00236	CbGeAlD
Prazosin—KCNH2—endocrine gland—germ cell cancer	0.000178	0.00233	CbGeAlD
Prazosin—Asthenia—Ifosfamide—germ cell cancer	0.000177	0.00404	CcSEcCtD
Prazosin—ABCG2—bone marrow—germ cell cancer	0.000177	0.00232	CbGeAlD
Prazosin—HTR1A—cerebellum—germ cell cancer	0.000176	0.00231	CbGeAlD
Prazosin—ABCG2—spinal cord—germ cell cancer	0.000176	0.00231	CbGeAlD
Prazosin—KCNH2—head—germ cell cancer	0.000176	0.0023	CbGeAlD
Prazosin—Feeling abnormal—Cisplatin—germ cell cancer	0.000175	0.004	CcSEcCtD
Prazosin—Paraesthesia—Etoposide—germ cell cancer	0.000175	0.00399	CcSEcCtD
Prazosin—ADRA2A—medulla oblongata—germ cell cancer	0.000175	0.00229	CbGeAlD
Prazosin—Pruritus—Ifosfamide—germ cell cancer	0.000174	0.00398	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—germ cell cancer	0.000174	0.00396	CcSEcCtD
Prazosin—SLC22A1—brain—germ cell cancer	0.000173	0.00227	CbGeAlD
Prazosin—Somnolence—Etoposide—germ cell cancer	0.000173	0.00395	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—germ cell cancer	0.000173	0.00394	CcSEcCtD
Prazosin—HTR1D—brain—germ cell cancer	0.000172	0.00225	CbGeAlD
Prazosin—Nausea—Bleomycin—germ cell cancer	0.000171	0.00391	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—germ cell cancer	0.000171	0.00391	CcSEcCtD
Prazosin—ABCG2—female gonad—germ cell cancer	0.00017	0.00223	CbGeAlD
Prazosin—KCNH2—testis—germ cell cancer	0.00017	0.00223	CbGeAlD
Prazosin—Rash—Dactinomycin—germ cell cancer	0.00017	0.00387	CcSEcCtD
Prazosin—Diarrhoea—Ifosfamide—germ cell cancer	0.000169	0.00385	CcSEcCtD
Prazosin—Body temperature increased—Cisplatin—germ cell cancer	0.000168	0.00384	CcSEcCtD
Prazosin—Fatigue—Etoposide—germ cell cancer	0.000168	0.00383	CcSEcCtD
Prazosin—Pain—Etoposide—germ cell cancer	0.000167	0.0038	CcSEcCtD
Prazosin—Constipation—Etoposide—germ cell cancer	0.000167	0.0038	CcSEcCtD
Prazosin—SLC22A3—brain—germ cell cancer	0.000166	0.00217	CbGeAlD
Prazosin—Dizziness—Ifosfamide—germ cell cancer	0.000163	0.00372	CcSEcCtD
Prazosin—ADRA1A—cerebellum—germ cell cancer	0.000162	0.00213	CbGeAlD
Prazosin—CYP1A1—female gonad—germ cell cancer	0.000162	0.00212	CbGeAlD
Prazosin—ADRA2A—adrenal gland—germ cell cancer	0.000162	0.00212	CbGeAlD
Prazosin—Feeling abnormal—Etoposide—germ cell cancer	0.00016	0.00366	CcSEcCtD
Prazosin—SLC22A3—lymph node—germ cell cancer	0.00016	0.0021	CbGeAlD
Prazosin—Nausea—Dactinomycin—germ cell cancer	0.00016	0.00365	CcSEcCtD
Prazosin—ADRA2A—midbrain—germ cell cancer	0.00016	0.00209	CbGeAlD
Prazosin—ABCB1—trigeminal ganglion—germ cell cancer	0.000158	0.00207	CbGeAlD
Prazosin—SLC22A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000157	0.00542	CbGpPWpGaD
Prazosin—KCNH2—cerebellum—germ cell cancer	0.000157	0.00206	CbGeAlD
Prazosin—Vomiting—Ifosfamide—germ cell cancer	0.000157	0.00358	CcSEcCtD
Prazosin—Hypersensitivity—Cisplatin—germ cell cancer	0.000157	0.00358	CcSEcCtD
Prazosin—ADRA2A—spinal cord—germ cell cancer	0.000156	0.00204	CbGeAlD
Prazosin—Rash—Ifosfamide—germ cell cancer	0.000155	0.00355	CcSEcCtD
Prazosin—Dermatitis—Ifosfamide—germ cell cancer	0.000155	0.00355	CcSEcCtD
Prazosin—Urticaria—Etoposide—germ cell cancer	0.000155	0.00353	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—germ cell cancer	0.000154	0.00352	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—germ cell cancer	0.000153	0.0035	CcSEcCtD
Prazosin—Asthenia—Cisplatin—germ cell cancer	0.000153	0.00348	CcSEcCtD
Prazosin—ABCB1—embryo—germ cell cancer	0.000152	0.002	CbGeAlD
Prazosin—ABCG2—testis—germ cell cancer	0.000151	0.00198	CbGeAlD
Prazosin—ADRA2A—female gonad—germ cell cancer	0.000151	0.00198	CbGeAlD
Prazosin—CYP1A1—endocrine gland—germ cell cancer	0.00015	0.00197	CbGeAlD
Prazosin—CYP1A1—head—germ cell cancer	0.000148	0.00195	CbGeAlD
Prazosin—Nausea—Ifosfamide—germ cell cancer	0.000146	0.00334	CcSEcCtD
Prazosin—Diarrhoea—Cisplatin—germ cell cancer	0.000145	0.00332	CcSEcCtD
Prazosin—Alopecia—Methotrexate—germ cell cancer	0.000145	0.00331	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—germ cell cancer	0.000143	0.00328	CcSEcCtD
Prazosin—HTR1A—brain—germ cell cancer	0.000143	0.00188	CbGeAlD
Prazosin—ADRA2A—endocrine gland—germ cell cancer	0.00014	0.00184	CbGeAlD
Prazosin—Asthenia—Etoposide—germ cell cancer	0.00014	0.00319	CcSEcCtD
Prazosin—ABCG2—cerebellum—germ cell cancer	0.000139	0.00183	CbGeAlD
Prazosin—ADRA2A—head—germ cell cancer	0.000138	0.00181	CbGeAlD
Prazosin—Pruritus—Etoposide—germ cell cancer	0.000138	0.00315	CcSEcCtD
Prazosin—Vomiting—Cisplatin—germ cell cancer	0.000135	0.00309	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—germ cell cancer	0.000135	0.00308	CcSEcCtD
Prazosin—ABCB1—retina—germ cell cancer	0.000135	0.00176	CbGeAlD
Prazosin—Rash—Cisplatin—germ cell cancer	0.000134	0.00306	CcSEcCtD
Prazosin—Dermatitis—Cisplatin—germ cell cancer	0.000134	0.00306	CcSEcCtD
Prazosin—ADRA2A—testis—germ cell cancer	0.000134	0.00175	CbGeAlD
Prazosin—Diarrhoea—Etoposide—germ cell cancer	0.000133	0.00304	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—germ cell cancer	0.000133	0.00303	CcSEcCtD
Prazosin—ADRA1A—brain—germ cell cancer	0.000132	0.00173	CbGeAlD
Prazosin—Malaise—Methotrexate—germ cell cancer	0.000129	0.00294	CcSEcCtD
Prazosin—Dizziness—Etoposide—germ cell cancer	0.000129	0.00294	CcSEcCtD
Prazosin—Vertigo—Methotrexate—germ cell cancer	0.000128	0.00293	CcSEcCtD
Prazosin—KCNH2—brain—germ cell cancer	0.000127	0.00167	CbGeAlD
Prazosin—Nausea—Cisplatin—germ cell cancer	0.000126	0.00288	CcSEcCtD
Prazosin—Vomiting—Etoposide—germ cell cancer	0.000124	0.00283	CcSEcCtD
Prazosin—ABCB1—telencephalon—germ cell cancer	0.000124	0.00162	CbGeAlD
Prazosin—ADRA2A—cerebellum—germ cell cancer	0.000123	0.00162	CbGeAlD
Prazosin—KCNH2—lymph node—germ cell cancer	0.000123	0.00161	CbGeAlD
Prazosin—Rash—Etoposide—germ cell cancer	0.000123	0.0028	CcSEcCtD
Prazosin—Dermatitis—Etoposide—germ cell cancer	0.000123	0.0028	CcSEcCtD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000122	0.00421	CbGpPWpGaD
Prazosin—Headache—Etoposide—germ cell cancer	0.000122	0.00279	CcSEcCtD
Prazosin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000122	0.0042	CbGpPWpGaD
Prazosin—Arthralgia—Methotrexate—germ cell cancer	0.000122	0.00278	CcSEcCtD
Prazosin—Discomfort—Methotrexate—germ cell cancer	0.00012	0.00275	CcSEcCtD
Prazosin—ABCB1—decidua—germ cell cancer	0.000117	0.00154	CbGeAlD
Prazosin—HTR1A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000117	0.00402	CbGpPWpGaD
Prazosin—Nausea—Etoposide—germ cell cancer	0.000116	0.00264	CcSEcCtD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000114	0.00391	CbGpPWpGaD
Prazosin—ABCG2—brain—germ cell cancer	0.000113	0.00149	CbGeAlD
Prazosin—Hyperhidrosis—Methotrexate—germ cell cancer	0.000113	0.00258	CcSEcCtD
Prazosin—KCNH2—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00011	0.00378	CbGpPWpGaD
Prazosin—ABCG2—lymph node—germ cell cancer	0.000109	0.00144	CbGeAlD
Prazosin—CYP1A1—brain—germ cell cancer	0.000108	0.00141	CbGeAlD
Prazosin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000106	0.00243	CcSEcCtD
Prazosin—Insomnia—Methotrexate—germ cell cancer	0.000106	0.00241	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—germ cell cancer	0.000105	0.00239	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—germ cell cancer	0.000104	0.00237	CcSEcCtD
Prazosin—CYP1A1—lymph node—germ cell cancer	0.000104	0.00136	CbGeAlD
Prazosin—Somnolence—Methotrexate—germ cell cancer	0.000104	0.00237	CcSEcCtD
Prazosin—ABCB1—gonad—germ cell cancer	0.000103	0.00135	CbGeAlD
Prazosin—ABCB1—uterus—germ cell cancer	0.000103	0.00135	CbGeAlD
Prazosin—ABCB1—pituitary gland—germ cell cancer	0.000101	0.00132	CbGeAlD
Prazosin—Fatigue—Methotrexate—germ cell cancer	0.000101	0.0023	CcSEcCtD
Prazosin—ADRA2A—brain—germ cell cancer	0.0001	0.00131	CbGeAlD
Prazosin—Pain—Methotrexate—germ cell cancer	9.98e-05	0.00228	CcSEcCtD
Prazosin—ADRA1D—G alpha (q) signalling events—OXT—germ cell cancer	9.96e-05	0.00344	CbGpPWpGaD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.86e-05	0.0034	CbGpPWpGaD
Prazosin—ABCB1—medulla oblongata—germ cell cancer	9.73e-05	0.00128	CbGeAlD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.71e-05	0.00335	CbGpPWpGaD
Prazosin—ADRA2A—lymph node—germ cell cancer	9.69e-05	0.00127	CbGeAlD
Prazosin—Feeling abnormal—Methotrexate—germ cell cancer	9.61e-05	0.0022	CcSEcCtD
Prazosin—Urticaria—Methotrexate—germ cell cancer	9.27e-05	0.00212	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—germ cell cancer	9.22e-05	0.00211	CcSEcCtD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.19e-05	0.00317	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.05e-05	0.00312	CbGpPWpGaD
Prazosin—ABCB1—adrenal gland—germ cell cancer	9.01e-05	0.00118	CbGeAlD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	8.91e-05	0.00307	CbGpPWpGaD
Prazosin—ABCB1—midbrain—germ cell cancer	8.89e-05	0.00117	CbGeAlD
Prazosin—ABCB1—bone marrow—germ cell cancer	8.71e-05	0.00114	CbGeAlD
Prazosin—ABCB1—spinal cord—germ cell cancer	8.67e-05	0.00114	CbGeAlD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—CD9—germ cell cancer	8.61e-05	0.00297	CbGpPWpGaD
Prazosin—Hypersensitivity—Methotrexate—germ cell cancer	8.6e-05	0.00196	CcSEcCtD
Prazosin—ABCB1—female gonad—germ cell cancer	8.4e-05	0.0011	CbGeAlD
Prazosin—Asthenia—Methotrexate—germ cell cancer	8.37e-05	0.00191	CcSEcCtD
Prazosin—ADRA1B—G alpha (q) signalling events—OXT—germ cell cancer	8.27e-05	0.00285	CbGpPWpGaD
Prazosin—Pruritus—Methotrexate—germ cell cancer	8.25e-05	0.00188	CcSEcCtD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.99e-05	0.00276	CbGpPWpGaD
Prazosin—Diarrhoea—Methotrexate—germ cell cancer	7.98e-05	0.00182	CcSEcCtD
Prazosin—ABCB1—endocrine gland—germ cell cancer	7.81e-05	0.00102	CbGeAlD
Prazosin—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.74e-05	0.00267	CbGpPWpGaD
Prazosin—Dizziness—Methotrexate—germ cell cancer	7.71e-05	0.00176	CcSEcCtD
Prazosin—ABCB1—head—germ cell cancer	7.71e-05	0.00101	CbGeAlD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	7.71e-05	0.00266	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.66e-05	0.00264	CbGpPWpGaD
Prazosin—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	7.56e-05	0.00261	CbGpPWpGaD
Prazosin—ABCB1—testis—germ cell cancer	7.45e-05	0.000976	CbGeAlD
Prazosin—Vomiting—Methotrexate—germ cell cancer	7.42e-05	0.00169	CcSEcCtD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	7.39e-05	0.00255	CbGpPWpGaD
Prazosin—Rash—Methotrexate—germ cell cancer	7.36e-05	0.00168	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—germ cell cancer	7.35e-05	0.00168	CcSEcCtD
Prazosin—ADRA1A—G alpha (q) signalling events—OXT—germ cell cancer	7.34e-05	0.00253	CbGpPWpGaD
Prazosin—Headache—Methotrexate—germ cell cancer	7.31e-05	0.00167	CcSEcCtD
Prazosin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	7.27e-05	0.00251	CbGpPWpGaD
Prazosin—SLC22A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.25e-05	0.0025	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.14e-05	0.00246	CbGpPWpGaD
Prazosin—Nausea—Methotrexate—germ cell cancer	6.93e-05	0.00158	CcSEcCtD
Prazosin—HTR1A—SIDS Susceptibility Pathways—AVP—germ cell cancer	6.88e-05	0.00237	CbGpPWpGaD
Prazosin—ABCB1—cerebellum—germ cell cancer	6.88e-05	0.000902	CbGeAlD
Prazosin—ADRA1D—G alpha (q) signalling events—AVP—germ cell cancer	6.83e-05	0.00235	CbGpPWpGaD
Prazosin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	6.71e-05	0.00231	CbGpPWpGaD
Prazosin—KCNH7—Circadian rythm related genes—TP53—germ cell cancer	6.67e-05	0.0023	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	6.6e-05	0.00228	CbGpPWpGaD
Prazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	6.59e-05	0.00227	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	6.57e-05	0.00227	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	6.11e-05	0.00211	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.96e-05	0.00205	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—OXT—germ cell cancer	5.87e-05	0.00202	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—CD9—germ cell cancer	5.85e-05	0.00202	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.75e-05	0.00198	CbGpPWpGaD
Prazosin—ADRA1B—G alpha (q) signalling events—AVP—germ cell cancer	5.67e-05	0.00195	CbGpPWpGaD
Prazosin—ABCB1—brain—germ cell cancer	5.59e-05	0.000732	CbGeAlD
Prazosin—KCNH6—Neuronal System—HRAS—germ cell cancer	5.51e-05	0.0019	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.48e-05	0.00189	CbGpPWpGaD
Prazosin—ABCB1—lymph node—germ cell cancer	5.4e-05	0.000708	CbGeAlD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.28e-05	0.00182	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	5.07e-05	0.00175	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.06e-05	0.00175	CbGpPWpGaD
Prazosin—ADRA1A—G alpha (q) signalling events—AVP—germ cell cancer	5.03e-05	0.00174	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—OXT—germ cell cancer	5.02e-05	0.00173	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.01e-05	0.00173	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.99e-05	0.00172	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.94e-05	0.0017	CbGpPWpGaD
Prazosin—KCNH7—Neuronal System—HRAS—germ cell cancer	4.91e-05	0.00169	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	4.86e-05	0.00168	CbGpPWpGaD
Prazosin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.78e-05	0.00165	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.67e-05	0.00161	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.6e-05	0.00159	CbGpPWpGaD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.55e-05	0.00157	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—OXT—germ cell cancer	4.54e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.52e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	4.52e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	4.5e-05	0.00155	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—CD9—germ cell cancer	4.44e-05	0.00153	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—OXT—germ cell cancer	4.38e-05	0.00151	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.24e-05	0.00146	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.18e-05	0.00144	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—OXT—germ cell cancer	4.17e-05	0.00144	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.08e-05	0.00141	CbGpPWpGaD
Prazosin—ADRA1B—LPA receptor mediated events—HRAS—germ cell cancer	4.03e-05	0.00139	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—AVP—germ cell cancer	4.02e-05	0.00139	CbGpPWpGaD
Prazosin—ADRA1B—AMPK Signaling—TP53—germ cell cancer	3.97e-05	0.00137	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.94e-05	0.00136	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.75e-05	0.00129	CbGpPWpGaD
Prazosin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.75e-05	0.00129	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—SLC2A3—germ cell cancer	3.74e-05	0.00129	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—OXT—germ cell cancer	3.7e-05	0.00128	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—AVP—germ cell cancer	3.68e-05	0.00127	CbGpPWpGaD
Prazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.63e-05	0.00125	CbGpPWpGaD
Prazosin—ADRA1A—AMPK Signaling—TP53—germ cell cancer	3.53e-05	0.00122	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—AVP—germ cell cancer	3.44e-05	0.00119	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—OXT—germ cell cancer	3.44e-05	0.00119	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.33e-05	0.00115	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—OXT—germ cell cancer	3.32e-05	0.00114	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—AVP—germ cell cancer	3.11e-05	0.00107	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.1e-05	0.00107	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—OXT—germ cell cancer	3.01e-05	0.00104	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CRABP1—germ cell cancer	3e-05	0.00104	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—AVP—germ cell cancer	3e-05	0.00103	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.89e-05	0.000998	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—AVP—germ cell cancer	2.86e-05	0.000986	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—OXT—germ cell cancer	2.84e-05	0.000979	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.74e-05	0.000944	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.7e-05	0.00093	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—OXT—germ cell cancer	2.58e-05	0.000889	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—OXT—germ cell cancer	2.56e-05	0.000884	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—AVP—germ cell cancer	2.54e-05	0.000875	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—OXT—germ cell cancer	2.47e-05	0.000853	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SLC2A3—germ cell cancer	2.37e-05	0.000818	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—AVP—germ cell cancer	2.36e-05	0.000813	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—OXT—germ cell cancer	2.36e-05	0.000813	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SLC2A3—germ cell cancer	2.35e-05	0.000809	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—SLC22A3—germ cell cancer	2.34e-05	0.000806	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.34e-05	0.000805	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—OXT—germ cell cancer	2.33e-05	0.000803	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—SLC22A3—germ cell cancer	2.31e-05	0.000797	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.31e-05	0.000797	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AVP—germ cell cancer	2.27e-05	0.000784	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—OXT—germ cell cancer	2.25e-05	0.000775	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SLC2A3—germ cell cancer	2.19e-05	0.000754	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—SLC22A3—germ cell cancer	2.15e-05	0.000743	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.15e-05	0.000743	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—OXT—germ cell cancer	2.14e-05	0.000738	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—OXT—germ cell cancer	2.09e-05	0.000722	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—HRAS—germ cell cancer	2.08e-05	0.000717	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AVP—germ cell cancer	2.06e-05	0.000712	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AVP—germ cell cancer	1.95e-05	0.000671	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—OXT—germ cell cancer	1.94e-05	0.000671	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CRABP1—germ cell cancer	1.9e-05	0.000657	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—OXT—germ cell cancer	1.9e-05	0.000655	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CRABP1—germ cell cancer	1.88e-05	0.00065	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SLC2A3—germ cell cancer	1.85e-05	0.000639	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.84e-05	0.000635	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—SLC22A3—germ cell cancer	1.83e-05	0.00063	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—OXT—germ cell cancer	1.78e-05	0.000614	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AVP—germ cell cancer	1.77e-05	0.000609	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—OXT—germ cell cancer	1.77e-05	0.000609	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AVP—germ cell cancer	1.76e-05	0.000606	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CRABP1—germ cell cancer	1.76e-05	0.000606	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AVP—germ cell cancer	1.7e-05	0.000585	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.69e-05	0.000584	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AVP—germ cell cancer	1.62e-05	0.000557	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SLC2A3—germ cell cancer	1.61e-05	0.000554	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AVP—germ cell cancer	1.6e-05	0.00055	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—SLC22A3—germ cell cancer	1.58e-05	0.000545	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.58e-05	0.000544	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AVP—germ cell cancer	1.54e-05	0.000531	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.53e-05	0.000527	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—OXT—germ cell cancer	1.52e-05	0.000525	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—FGF4—germ cell cancer	1.52e-05	0.000524	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CRABP1—germ cell cancer	1.49e-05	0.000513	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AVP—germ cell cancer	1.47e-05	0.000506	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AVP—germ cell cancer	1.43e-05	0.000495	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—OXT—germ cell cancer	1.38e-05	0.000474	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.36e-05	0.000468	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—H2AFZ—germ cell cancer	1.36e-05	0.000468	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AVP—germ cell cancer	1.33e-05	0.00046	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—OXT—germ cell cancer	1.33e-05	0.000458	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AVP—germ cell cancer	1.3e-05	0.000449	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGF4—germ cell cancer	1.3e-05	0.000448	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—HRAS—germ cell cancer	1.3e-05	0.000447	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CRABP1—germ cell cancer	1.29e-05	0.000445	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.28e-05	0.000442	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—OXT—germ cell cancer	1.26e-05	0.000436	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.26e-05	0.000436	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.26e-05	0.000435	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KITLG—germ cell cancer	1.25e-05	0.00043	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.22e-05	0.000421	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AVP—germ cell cancer	1.22e-05	0.000421	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	1.21e-05	0.000417	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—HRAS—germ cell cancer	1.21e-05	0.000417	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGF4—germ cell cancer	1.17e-05	0.000405	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—H2AFZ—germ cell cancer	1.16e-05	0.0004	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGF4—germ cell cancer	1.13e-05	0.000391	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—OXT—germ cell cancer	1.12e-05	0.000387	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	1.08e-05	0.000372	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KITLG—germ cell cancer	1.07e-05	0.000368	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—H2AFZ—germ cell cancer	1.05e-05	0.000361	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AVP—germ cell cancer	1.04e-05	0.00036	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—OXT—germ cell cancer	1.04e-05	0.00036	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CRABP1—germ cell cancer	1.03e-05	0.000355	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—H2AFZ—germ cell cancer	1.01e-05	0.000349	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1e-05	0.000346	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KITLG—germ cell cancer	9.64e-06	0.000333	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	9.64e-06	0.000332	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	9.58e-06	0.00033	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AVP—germ cell cancer	9.42e-06	0.000325	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KITLG—germ cell cancer	9.31e-06	0.000321	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—FGFR3—germ cell cancer	9.27e-06	0.00032	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AVP—germ cell cancer	9.1e-06	0.000314	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	8.9e-06	0.000307	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	8.86e-06	0.000306	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—germ cell cancer	8.77e-06	0.000302	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AVP—germ cell cancer	8.66e-06	0.000299	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	8.56e-06	0.000295	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—KIT—germ cell cancer	8.51e-06	0.000294	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—HRAS—germ cell cancer	8.39e-06	0.000289	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	7.95e-06	0.000274	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGFR3—germ cell cancer	7.94e-06	0.000274	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	7.87e-06	0.000272	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AVP—germ cell cancer	7.7e-06	0.000265	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	7.32e-06	0.000252	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KIT—germ cell cancer	7.29e-06	0.000251	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGFR3—germ cell cancer	7.17e-06	0.000247	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AVP—germ cell cancer	7.15e-06	0.000247	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGFR3—germ cell cancer	6.92e-06	0.000239	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—germ cell cancer	6.65e-06	0.000229	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	6.59e-06	0.000227	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KIT—germ cell cancer	6.58e-06	0.000227	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—HRAS—germ cell cancer	6.36e-06	0.000219	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KIT—germ cell cancer	6.35e-06	0.000219	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HRAS—germ cell cancer	6.23e-06	0.000215	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KIT—germ cell cancer	6.05e-06	0.000209	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	5.85e-06	0.000202	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	5.44e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KIT—germ cell cancer	5.37e-06	0.000185	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HRAS—germ cell cancer	5.33e-06	0.000184	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KIT—germ cell cancer	4.99e-06	0.000172	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HRAS—germ cell cancer	4.81e-06	0.000166	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MYC—germ cell cancer	4.69e-06	0.000162	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HRAS—germ cell cancer	4.65e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	4.42e-06	0.000153	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MYC—germ cell cancer	4.01e-06	0.000138	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	3.93e-06	0.000136	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—germ cell cancer	3.85e-06	0.000133	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HRAS—germ cell cancer	3.68e-06	0.000127	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	3.65e-06	0.000126	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MYC—germ cell cancer	3.62e-06	0.000125	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MYC—germ cell cancer	3.49e-06	0.000121	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MYC—germ cell cancer	3.33e-06	0.000115	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—germ cell cancer	3.29e-06	0.000114	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HRAS—germ cell cancer	3.15e-06	0.000109	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—germ cell cancer	2.97e-06	0.000103	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MYC—germ cell cancer	2.96e-06	0.000102	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—germ cell cancer	2.87e-06	9.9e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HRAS—germ cell cancer	2.84e-06	9.81e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MYC—germ cell cancer	2.75e-06	9.47e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HRAS—germ cell cancer	2.74e-06	9.47e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—germ cell cancer	2.73e-06	9.43e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	2.61e-06	9.01e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—germ cell cancer	2.43e-06	8.37e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	2.32e-06	8.01e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—germ cell cancer	2.26e-06	7.78e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	2.16e-06	7.44e-05	CbGpPWpGaD
